Ergoteles LLC - OVID THERAPEUTICS INC ownership

OVID THERAPEUTICS INC's ticker is OVID and the CUSIP is 690469101. A total of 61 filers reported holding OVID THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
Ergoteles LLC ownership history of OVID THERAPEUTICS INC
ValueSharesWeighting
Q4 2022$141,217
-74.8%
75,923
-54.4%
0.01%
-76.2%
Q3 2021$560,000
-27.5%
166,668
-15.6%
0.02%
+16.7%
Q2 2021$772,000
+418.1%
197,389
+660.7%
0.02%
-10.0%
Q3 2020$149,00025,9470.02%
Other shareholders
OVID THERAPEUTICS INC shareholders Q4 2022
NameSharesValueWeighting ↓
TLS Advisors LLC 1,319,679$4,32918.57%
Madison Avenue Partners, LP 3,307,605$10,848,9432.37%
CHI Advisors LLC 864,822$2,836,6160.86%
Rubric Capital Management LP 5,445,910$17,862,5850.76%
BVF INC/IL 6,851,051$22,471,4470.63%
EcoR1 Capital, LLC 6,117,400$20,065,0720.49%
Artal Group S.A. 2,500,000$8,2000.25%
Tejara Capital Ltd 112,591$369,2980.18%
DCF Advisers, LLC 64,764$212,4260.11%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 801,152$2,627,7790.06%
View complete list of OVID THERAPEUTICS INC shareholders